A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients
在肝移植受者中,第三剂BNT162b2 mRNA疫苗可显著提高对SARS-CoV-2变异株的中和活性。
期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.6
doi:10.3389/fcimb.2023.1197349
Takahiro Tomiyama,Rigel Suzuki,Noboru Harada,Tomokazu Tamura,Katsuya Toshida,Yukiko- Kosai-Fujimoto,Takahiro Tomino,Shohei Yoshiya,Yoshihiro Nagao,Kazuki Takeishi,Shinji Itoh,Nobuhiro Kobayashi,Hayato Ito,Sachiyo Yoshio,Tatsuya Kanto,Tomoharu Yoshizumi,Takasuke Fukuhara